Earli
Earli is a Stanford spinout developing a new approach to cancer treatment and tackling the “holy grail” in oncology of destroying cancer cells while safeguarding healthy ones. Rather than playing by cancer’s rules, Earli’s technology re-engineers cancer cells to kill themselves. The company’s therapeutics platform designs programmable genetic constructs. These infiltrate cancer cells and then reprogram them into “factories” that produce immune-activating proteins that trigger self-destruction. This new approach enables scientists to control cancer cells for the first time and forces cancer cells to consistently produce the same target of choice across all patients.Content by Earli
Page 1 of 1 - 1 Total Items
